Wellment Financial
Long book
$80.8M
Q1 2026
Positions
38
Top-10 weight
68%
concentration
Last quarter
+8.0%
SPY +14.8%
Turnover
35%
of book per quarter
Strategy in plain words
auto-generated from filingsWellment Financial is a wealth-management firm allocating client money, running a $80.8M US long book across 38 positions.
The portfolio is concentrated: the top 10 names carry 68% of the portfolio. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: ALLIANZIM US BF15 UNCAP DEC, FT VEST US EQUITY MODERATE B, ALLIAN US EQU 6 MON BU10-USD, ALIANZIM US EQ BFR20 OCT-USD, ALIANZIM US EQ BFR20 JAN-USD.
Over the last 6 quarters its long book ran on average 1.8pp per quarter behind the S&P 500, beating the index in 2 of 6 quarters. Its holdings are mechanical (indexing / client flows), so position changes carry no stock-picking signal.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q4 2024
-2.0%
Q1 2025
+7.0%
Q2 2025
+4.3%
Q3 2025
+1.8%
Q4 2025
-2.5%
Q1 2026
+8.0%
Sector allocation
Technology 61%
Healthcare 33%
Industrials 6%
Long book by quarter
What does Wellment Financial own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| META META PLATFORMS INC-CLASS A | Technology | 3.0K | $1.7M | 2.1% | -0.6% |
| ABBV ABBVIE INC | Healthcare | 5.5K | $1.2M | 1.5% | New |
| NVDA NVIDIA CORP | Technology | 4.7K | $812K | 1.0% | -0.8% |
| AAPL APPLE INC | Technology | 2.9K | $736K | 0.9% | -6.4% |
| ABT ABBOTT LABORATORIES | Healthcare | 6.3K | $650K | 0.8% | New |
| TSLA TESLA INC | Industrials | 899 | $334K | 0.4% | -1.5% |
| CSCO CISCO SYSTEMS INC | Technology | 2.7K | $208K | 0.3% | -1.8% |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | Apr 28, 2026 | 38 | $80.8M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Jan 27, 2026 | 38 | $85.1M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Oct 29, 2025 | 34 | $84.5M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Jul 31, 2025 | 35 | $77.9M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | Apr 28, 2025 | 39 | $75.8M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Jan 29, 2025 | 41 | $79.6M | canonical | SEC ↗ |
| Q3 2024 | 13F-NT | Nov 8, 2024 | — | $0 | SEC ↗ | |
| Q1 2024 | 13F-NT | Apr 26, 2024 | — | $0 | SEC ↗ |